Back to dashboard
Medicare AdvantageCoverageMedium impact

Medical policy updates

Blue Cross Blue Shield of Rhode Island·RI · Diagnostic Imaging, Oncology, Cardiology·Physician / Facility
Effective date
May 1, 2025
We identified it
Jun 19, 2026
Days to comply

Summary

BCBSRI has updated medical policies effective May 1 and June 1, 2025, affecting prior authorization requirements for durable medical equipment, expanding covered diagnosis codes for CA-125 testing and cardiovascular biomarker testing, and adding new requirements for human leukocyte antigen testing with mandatory modifier usage.

Action Required

Action needed
By May 1, 2025: Update billing system to include new covered ICD-10 codes E10.A0-E10.A2, E88.810, E88.82 for CPT codes 83700, 83701, 83704 and codes T45.AX1A-T45.AX5S, Z92.26 for CPT 82610. By June 1, 2025: Configure system to use web-based authorization tool for HCPCS E2513, add ICD-10 codes R19.01-R19.04 as covered for CPT 86304, and ensure Modifier 32 is automatically applied to CPT codes 81370-81383 and 86812, 86817, 86821, 86825, 86826, 86829-86835 for Rhode Island HLA testing mandate.

Affected Billing Codes

E2513
R19.01
R19.02
R19.03
R19.04
86304
81370
81371
81372
81373
81374
81375
81376
81377
81378
81379
81380
81381
81382
81383
86812
86817
86821
86825
86826
86829
86830
86831
86832
86833
86834
86835
E10.A0
E10.A1
E10.A2
E88.810
E88.82
83700
83701
83704
T45.AX1A
T45.AX5S
Z92.26
82610